Back to VANGUARD GROUP INC VANGUARD GROUP INC

XERSXERS
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in XERIS BIOPHARMA HOLDINGS INC

As of its last 13F, for Q4 2025, Vanguard Group held 11,186,677 shares of XERS (Xeris Biopharma Holdings), worth $87.8M. It increased the position by 1,358,760 shares (+13.8%) from Q3 2025. Vanguard Group held XERS from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.

Current Value

$87.8M

Current Shares

11.2M

Total Value Change

+$65.7M

Total Shares Change

+3.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
11.2M
+13.8%
$87.8M0.0%$7.31
34
2025-Q3
Increased
9.8M
+0.1%
$80M0.0%$8.08
30
2025-Q2
Increased
9.8M
+21.1%
$45.8M0.0%$4.70
35
2025-Q1
Increased
8.1M
+2.7%
$44.5M0.0%$5.58
30
2024-Q4
Increased
7.9M
+1.7%
$26.8M0.0%$3.38
29
2024-Q3
First report
7.8M
-
$22.1M0.0%$2.87
0

Other major holders of XERS: BlackRock, Inc., D. E. Shaw & Co., Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used